Drug
safety advice |
|
Bevacizumab
and sunitinib: risk of osteonecrosis of the jaw |
|
Insulin
combined with pioglitazone: risk of cardiac failure
|
|
Sitaxentan
(Thelin): worldwide withdrawal from the market due to hepatotoxicity |
Hot
topics |
|
(Dextro)propoxyphene:
new studies confirm cardiac risks |
Stop
Press |
|
Moxifloxacin:
use in pelvic inflammatory disease only when other antibacterials
are inappropriate or ineffective |
|
Seasonal
flu vaccines: no evidence of increased risk of febrile convulsions
in children |
|
Implanon
contraceptive implant: information for women and healthcare professionals |